The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
RAKT
A Retrospective Cohort Study of Prospectively Collect the Outcomes of Recipients After Robot-assisted Kidney Transplantation
1 other identifier
observational
400
1 country
1
Brief Summary
The technology for robot-assisted kidney transplantation (RAKT) has become increasingly advanced, with numerous studies demonstrating comparable outcomes between RAKT surgery and open surgery. This advancement is particularly noteworthy as it extends its suitability to transplant patients with obesity. It will be important to explore the results of robot-assisted kidney transplantation as compared with open surgery or within cohorts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 24, 2024
CompletedFirst Posted
Study publicly available on registry
August 29, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 3, 2024
August 1, 2024
3.5 years
August 24, 2024
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The graft function of recipients
the graft function of recipients per month after transplant surgery, assessed by the serum creatinine (umol/L) and estimated glomerular function rate (eGFR).
in the follow-up period,about six months to one year
Secondary Outcomes (1)
total operative time
about 150 minutes to 300 minutes
Study Arms (2)
grafts with a single artery (GSA)
recipients of grafts with a single artery undergoing living donor robotic-assisted kidney transplantation
grafts with multiple single arteries (GMA)
recipients of grafts with multiple renal arteries undergoing living donor robotic-assisted kidney transplantation
Eligibility Criteria
Patients with stage 5 chronic kidney disease undergoing living robot-assisted kidney transplantation
You may qualify if:
- living-donor kidney transplant recipients
- receiving standard triad immunosuppressive regimen
You may not qualify if:
- active infection
- multi-organ transplantation
- malignancy history in the donor and recipient
- human immunodeficiency virus infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Related Publications (1)
Tang Y, Zhang H, Yin S, Li Y, Zeng J, Lin T, Song T. The Early Outcomes of Robotic-Assisted Kidney Transplantation Using Grafts With Multiple Arteries From a High-Volume Center: A Retrospective Cohort Study. Clin Transplant. 2025 Oct;39(10):e70328. doi: 10.1111/ctr.70328.
PMID: 40988626DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Tao Lin
Study Record Dates
First Submitted
August 24, 2024
First Posted
August 29, 2024
Study Start
July 1, 2020
Primary Completion
January 1, 2024
Study Completion
December 1, 2025
Last Updated
September 3, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share